Related references
Note: Only part of the references are listed.Apolipoprotein A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats
Ben J. Wu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Insulin regulation of gluconeogenesis
Maximilian Hatting et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1
Noriko Matsushita et al.
PLOS ONE (2017)
LAPSInsulin115: A novel ultra-long-acting basal insulin with a unique action profile
Nina Wronkowitz et al.
DIABETES OBESITY & METABOLISM (2017)
Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action
S. J. Jacober et al.
DIABETES OBESITY & METABOLISM (2016)
Proinsulin-Transferrin Fusion Protein as a Novel Long-Acting Insulin Analog for the Inhibition of Hepatic Glucose Production
Yan Wang et al.
DIABETES (2014)
A Multiple Ascending Dose Study of CSL112, an Infused Formulation of ApoA-I
Rachael Easton et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Insulin degludec: overview of a novel ultra long-acting basal insulin
S. C. L. Gough et al.
DIABETES OBESITY & METABOLISM (2013)
A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy
Yang Ding et al.
BIOMATERIALS (2012)
The emerging role of HDL in glucose metabolism
Brian G. Drew et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism
Carolina Huaman Samanez et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2012)
Insulin-dependent suppression of cholesterol 7α-hydroxlase is a possible link between glucose and cholesterol metabolisms
Wook-Ha Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat
Xiangbo Ruan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor
A. R. Sorensen et al.
DIABETES OBESITY & METABOLISM (2010)
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
Mark R. Sommerfeld et al.
PLOS ONE (2010)
Effect of Adeno-Associated Virus Serotype and Genomic Structure on Liver Transduction and Biodistribution in Mice of Both Genders
Astrid Paneda et al.
HUMAN GENE THERAPY (2009)
Single-Chain Insulins as Receptor Agonists
Gautam Rajpal et al.
MOLECULAR ENDOCRINOLOGY (2009)
Identification of a novel AS160 splice variant that regulates GLUT4 translocation and glucose-uptake in rat muscle cells
Daniela Baus et al.
CELLULAR SIGNALLING (2008)
Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I
Soo In Kim et al.
MOLECULAR THERAPY (2007)
Development of a long-acting insulin analog using albumin fusion technology
A Duttaroy et al.
DIABETES (2005)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients
A Gastaldelli et al.
DIABETES (2001)
Novel hepatoselective insulin analog -: Studies with a covalently linked thyroxyl-insulin complex in humans
F Shojaee-Moradie et al.
DIABETES CARE (2000)